You are here

Article info

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0187 Tocilizumab Standard Dose is an Overtreatment with Regard to Systemic IL-6 Receptor Blockade in Rheumatoid Arthritis

Authors

Citation

Kneepkens E, van den Oever I, Plasencia C, et al
SAT0187 Tocilizumab Standard Dose is an Overtreatment with Regard to Systemic IL-6 Receptor Blockade in Rheumatoid Arthritis
Annals of the Rheumatic Diseases 2015;74:723.

Publication history

  • First published June 9, 2015.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions